Healthtech Startups

Neurosynaptic Communications provides customized healthcare delivery solutions and telemedicine services designed for primary healthcare centers and underserved regions. The company combines technology platforms like ReMeDi® Kits and Platform with hands-on service delivery to improve healthcare access, affordability, and operational efficiency.

2 investors

NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.

2 investors

NeuroWyzr is a clinical neuroscience company that builds gamified digital assessments and care products for early detection, diagnosis, monitoring and prevention of brain decline. Its offerings use clinical evidence and AI-powered analytics to support brain health and mental wellbeing, with a focus on the Asia-Pacific market.

2 investors

NeuWave Medical develops the NeuWave Microwave Ablation System, a device used by healthcare professionals to ablate soft tissue, including non-resectable liver tumors, in percutaneous, open surgical, and laparoscopic settings. The system includes a probe portfolio and ABLATE-IQ software for margin confirmation, and is marketed for use in the United States; the company is a wholly owned subsidiary of Quantum Surgical, Inc.

2 investors

Nevro develops spinal cord stimulation systems for pain management, offering the Senza Trial Stimulator with high-frequency therapy options and wireless capability for patient trials and treatment.

2 investors

Shanghai NewMed Medical is a Chinese medical device company founded in 2015 that develops, manufactures, and sells transcatheter artificial heart valves and interventional ventricular assist systems. Its products target interventional treatment of cardiovascular disease for clinicians and patients in China.

2 investors

NEX builds artificial intelligence systems to help hospitals detect, track, and prevent healthcare-associated infections by analyzing connections between people, places, and transmission pathways. The platform serves hospital infection prevention, microbiology, and clinical teams to shift from reactive surveillance to proactive prevention.

2 investors

NexCure partners with health systems to build and operate outpatient treatment centers focused on delivering advanced cancer therapies such as CAR-T and T-cell engagers. Its platform combines AI-powered patient selection, remote monitoring, and standardized clinical protocols to bring these treatments to patients in outpatient settings across the country.

2 investors

Nexleaf develops digital health solutions and data systems for health equity in partnership with Ministries of Health and multilateral organizations. The company supports the transformation of health systems in low- and middle-income countries, particularly around vaccine management and health data.

2 investors

Next Innovation Inc. provides telemedicine and remote healthcare services in Japan. The company develops healthcare platforms and offers consulting services to medical institutions.

2 investors

Next Life Sciences works in reproductive healthcare, focused on solutions for couples.

2 investors

Cora Scribe is an AI-powered clinical documentation tool designed specifically for ophthalmology practices that listens to patient-provider conversations and automatically generates structured notes within the Nextech EHR. It reduces administrative burden by capturing documentation in real time while maintaining HIPAA compliance and clinical accuracy.

2 investors

Nexus-MD develops medical image management software integrated into athenaOne to streamline imaging workflows for healthcare clinics. The platform automates medical image sharing and accessibility to reduce administrative burden and improve patient care efficiency.

2 investors

NGM Bio is a biopharmaceutical company developing NGM120, a GDF15/GFRAL antagonist antibody, to treat conditions rooted in overactivation of the GDF15 pathway. Its current programs target hyperemesis gravidarum (extreme pregnancy sickness) and cancer cachexia, both in Phase 2 clinical trials.

2 investors

Nibec is a South Korean biotech company that develops peptide-based therapeutics and dental biomaterials, including bone graft materials, periodontal tissue regeneration products, tooth-whitening agents, and drug-delivery platforms. It supplies materials to global implant and pharmaceutical companies and pursues clinical development of treatments for conditions such as pulmonary fibrosis and inflammatory bowel disease.

2 investors

NightHawk Radiology provides 24/7 teleradiology and telemedicine services, offering diagnostic imaging interpretation by US-based, board-certified radiologists across multiple specialties. The company serves healthcare providers and medical facilities requiring remote radiology consultation and expert witness services.

2 investors

Nilo Therapeutics develops immunomodulation therapies that target brain-body neural circuits controlling systemic inflammation, aiming to treat autoimmune and inflammatory diseases. Its approach is focused on restoring immune homeostasis in conditions with large unmet medical need.

2 investors

A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas. The page content appears to redirect to AbbVie, and provides limited specific information about Nimble Therapeutics itself.

2 investors

NIRA develops at-home laser devices for skincare that deliver professional-grade results without pain or downtime, using patented semiconductor laser technology originally developed for dermatological clinics. The company manufactures its FDA-cleared devices in the USA and targets consumers seeking accessible professional skincare treatments.

2 investors

Nirva offers personalized lifestyle support programs including nutrition, yoga, and health coaching for individuals managing chronic conditions and lifestyle-related health issues. The service complements medical care to address digestive health, stress, sleep, chronic pain, and hormonal imbalances through evidence-based protocols delivered virtually across the UK.

2 investors

Nirvana Sciences develops dyes, probes, and contrast agents for life science applications, including organic dyes with narrow emission profiles and a library of over 700 chlorin and bacteriochlorin designs. Its products target life science research and imaging uses.

2 investors

Nisonic develops FAST-ICP software that uses transorbital ultrasound imaging and machine learning to non-invasively detect raised intracranial pressure by measuring optic nerve sheath properties. The software is designed to run on standard and handheld ultrasound devices for use by clinicians and neurosurgeons treating brain injury and neurological conditions.

2 investors

Nitinotes is an early-commercial-stage medical device company that makes EndoZip, an automated endoscopic suturing system for gastroplasty used to treat class I and II obesity in patients who do not qualify for traditional bariatric surgery. The device targets gastroenterologists and bariatric endoscopy units performing minimally invasive weight-loss procedures.

2 investors

Nivaan is India's largest centre for interventional pain management and regenerative medicine, offering integrated, non-surgical care for musculoskeletal and chronic pain through coordinated multidisciplinary teams of specialists, physiotherapists, and care managers.

2 investors